Purge Virus is pleased to provide these indoor air quality (IAQ Services) to help reduce the spread of COVID-19 during the pandemic and help increase safety and productivity for years to come beyond COVID-19 for businesses in Idaho.
Allergens, chemicals, and volatile organic compounds are all around us from products we buy to furniture and interior finishes. With many workplace environments that have closed windows and central HVAC systems, we are vulnerable to “Sick Building Syndrome” (SBS). According to ASHRAE, the estimated productivity decrement caused by SBS symptoms has an annual cost of $60 billion. A 20-50% reduction in these symptoms, considered feasible and practical, would bring annual economic benefits of $10 billion to $30 billion.
Clean Indoor Air = Safety and Savings
ASHRAE Estimated potential productivity gains from improvements in indoor environments.
Reduced respiratory illness: 16 to 37 million avoided cases of common cold or influenza: $6 – $14 billion
Reduced allergies and asthma: 8% to 25% decrease in symptoms within 53 million allergy sufferers and 16 million asthmatics: $1 – $4 billion
Reduced sick building syndrome symptoms: 20% to 50% reduction in SBS health symptoms experienced frequently at work by approximately 15 million workers: $10 – $30 billion
Improved worker performance from changes in thermal environment and lighting (beyond SBS): $20 – $160 billion
IAQ Services offered by Purge Virus include IAQ Assessment, IAQ Site Visit, PTAC Units, Mini Split Systems, and Ceiling Cassettes. These services will help reduce the spread of COVID-19 and promote Indoor Air Quality for businesses in Idaho.
For more news on COVID-19 in Idaho: When can you get a COVID-19 vaccination in Idaho? State provides timeline
“The Idaho Department of Health and Welfare laid out a timeline for when different groups of Idahoans ‘can get’ a COVID-19 vaccination in Idaho. It gives an estimate to residents wondering ‘when can I get a vaccination?’
The vaccine process started earlier this month, with doses from Pfizer-BioNTech arriving in the state. A second vaccine from Moderna began arriving last week. The two vaccines reported high levels of efficacy in trials. The Pfizer vaccine proved 95% effective in adults in preventing symptomatic COVID-19, and the Moderna vaccine proved 94.1% effective.
So far, 11,729 Idahoans have received at least one shot in the vaccination program, according to data from Health & Welfare. Both the Moderna and Pfizer vaccines require two shots – a prime dose, followed by a booster dose. The interval for the Moderna vaccine is 28 days, while for the Pfizer shot it’s 21 days.
Idaho has an estimated 1.787 million residents, meaning about .65% of residents have started the vaccination program.”